» Articles » PMID: 11751582

Methylation at Arginine 17 of Histone H3 is Linked to Gene Activation

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2001 Dec 26
PMID 11751582
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear hormone receptor co-activator CARM1 has the potential to methylate histone H3 at arginine residues in vitro. The methyltransferase activity of CARM1 is necessary for its co-activator functions in transient transfection assays. However, the role of this methyltransferase in vivo is unclear, given that methylation of arginines is not easily detectable on histones. We have raised an antibody that specifically recognizes methylated arginine 17 (R17) of histone H3, the major site of methylation by CARM1. Using this antibody we show that methylated R17 exists in vivo. Chromatin immunoprecipitation analysis shows that R17 methylation on histone H3 is dramatically upregulated when the estrogen receptor-regulated pS2 gene is activated. Coincident with the appearance of methylated R17, CARM1 is found associated with the histones on the pS2 gene. Together these results demonstrate that CARM1 is recruited to an active promoter and that CARM1-mediated R17 methylation on histone H3 takes place in vivo during this active state.

Citing Articles

Biomedical effects of protein arginine methyltransferase inhibitors.

Cao M, Nguyen T, Song J, Zheng Y J Biol Chem. 2025; 301(3):108201.

PMID: 39826691 PMC: 11871472. DOI: 10.1016/j.jbc.2025.108201.


Basic Epigenetic Mechanisms.

Davie J, Sattarifard H, Sudhakar S, Roberts C, Beacon T, Muker I Subcell Biochem. 2025; 108():1-49.

PMID: 39820859 DOI: 10.1007/978-3-031-75980-2_1.


The Effect of Maternal Diet and Lifestyle on the Risk of Childhood Obesity.

Luszczki E, Wyszynska J, Dymek A, Drozdz D, Gonzalez-Ramos L, Hartgring I Metabolites. 2024; 14(12).

PMID: 39728436 PMC: 11679592. DOI: 10.3390/metabo14120655.


Blocking CXCR4-CARM1-YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis.

Li Z, Lu H, Zhang Y, Lv J, Zhang Y, Xu T Cancer Sci. 2024; 115(10):3305-3319.

PMID: 39073190 PMC: 11447900. DOI: 10.1111/cas.16295.


The emerging role of CARM1 in cancer.

Xie Z, Tian Y, Guo X, Xie N Cell Oncol (Dordr). 2024; 47(5):1503-1522.

PMID: 38619752 PMC: 11466993. DOI: 10.1007/s13402-024-00943-9.


References
1.
Strahl B, Ohba R, Cook R, Allis C . Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A. 1999; 96(26):14967-72. PMC: 24756. DOI: 10.1073/pnas.96.26.14967. View

2.
Koh S, Chen D, Lee Y, Stallcup M . Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem. 2000; 276(2):1089-98. DOI: 10.1074/jbc.M004228200. View

3.
Kouzarides T . Acetylation: a regulatory modification to rival phosphorylation?. EMBO J. 2000; 19(6):1176-9. PMC: 305658. DOI: 10.1093/emboj/19.6.1176. View

4.
Lo W, Trievel R, Rojas J, Duggan L, Hsu J, Allis C . Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell. 2000; 5(6):917-26. DOI: 10.1016/s1097-2765(00)80257-9. View

5.
Rea S, Eisenhaber F, OCarroll D, Strahl B, Sun Z, Schmid M . Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000; 406(6796):593-9. DOI: 10.1038/35020506. View